Celerion (H.I.G. Capital)

Acquired

Celerion (H.I.G. Capital) is a biotech company in Lincoln, United States, founded in 2010. It has raised $45.0M across 4 rounds, most recently a Private Equity in November 2022.

Celerion: Translating Science to Medicine

Headquarters
Lincoln, Nebraska
Employees
501–1000
Founded
2010
Business Model
B2B
Total Funding
$45.0M
Last Round
Private EquityNov 2022
Rounds
4
Acquisition Date
Apr 2026

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 5 investors for this company. The full record is or through the API.

About

Celerion is a global clinical research organization with 50+ years of legacy history, specializing in early-phase clinical trials, bioanalytical sciences, and drug development services for pharmaceutical and biotechnology companies. Operating across North America and Europe with 650+ beds, Celerion conducts bioavailability, pharmacokinetic, and first-in-human studies through facilities in Lincoln NE, Phoenix AZ, and Belfast UK, serving clients from IND-enabling through proof-of-concept with proprietary platforms including ClinQuick and Celexus.

Summary

It lists 501–1000 employees. It has raised $45.0M in total across 4 rounds, most recently a Private Equity round in Nov 2022. Investors include Thomas H. Lee Partners, H.I.G. Capital and Court Square Capital Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionApr 2026

Sign up to see all 8 events

Funding: Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Celerion (H.I.G. Capital) on Indexed.vc
<a href="https://indexed.vc/companies/celerion-h-i-g-capital"><img src="https://indexed.vc/api/badge/company/celerion-h-i-g-capital" alt="Celerion (H.I.G. Capital) on Indexed.vc" width="260" height="76" /></a>